Regulatory News
Thursday, November 17, 2016
BRIEF-Resverlogix says announces successful phase 1 renal trial results
* Resverlogix - plans to initiate a phase 2 renal impairment
trial that is expected to commence in early 2017 based on pk
data confirmed in phase 1 trial
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment